🇬🇧·1d agoResearch
[ 177 Lu]-PSMA-617-PSMA-617 in oligometastatic hormone sensitive prostate cancer (BULLSEYE): an open-label, randomised, phase 2 study
Publisher
P
PubMed Lancet Oncology RSS
UK
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalIn-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on pubmed.ncbi.nlm.nih.gov
Leave the platform to read the original full article on the publisher site.
Source: PubMed Lancet Oncology RSS
Scope: Research
Related coverage
More related coverage
Science·18h ago
Offering scientists cash to spot errors in published papers doesn’t work
PubMed NEJM RSS·20h ago
Trastuzumab Deruxtecan in Residual HER2-Positive Early Breast Cancer
PubMed NEJM RSS·20h ago
The Fetal-to-Adult Hemoglobin Switch - Mechanism and Therapy
PubMed NEJM RSS·20h ago